Berkeley, California August 3, 2022 Channel Medsystems, Inc., a medical device company whose mission is to empower every woman to take control of her health journey, today announced that Heather Knight has joined the company’s Board of Directors. “We are pleased to welcome Heather to our Board of Directors,” said Chief Executive Officer Ric Cote. “Heather […]
Heather Knight Joins Channel Medsystems Board of Directors Read More »
Mind.Px provides clinically actionable information to physicians prior to treatment choice that significantly reduces “trial and error” biologic drug prescribing behavior, leading to improved psoriasis patient outcomes and reductions in wasted spending SAN DIEGO, CA – July 26, 2022 – Mindera Health announces the publication, in the Journal of Drugs in Dermatology, of the
MENLO PARK, Calif., July 19, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced the appointment of Tamara Fountain, M.D. to its Board of Directors, effective July 15, 2022. As part of her duties, Dr. Fountain
San Carlos, Calif. (July 12, 2022) – Empirical Spine, Inc., a medical device company creating a new class of spinal implant that works in parallel with the natural structures of the spine to restore functionality and optimize quality of life, recently had its Premarket Approval (PMA) Module II accepted and closed by the US Food
San Carlos, Calif. (July 12, 2022) – Empirical Spine, Inc., a medical device company creating a new class of spinal implant that works in parallel with the natural structures of the spine to restore functionality and optimize quality of life, recently had its Premarket Approval (PMA) Module II accepted and closed by the US Food
MENLO PARK, Calif., May 31, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on developing and commercializing innovative solutions intended to transform care and improve patients’ lives, today announced publication in Clinical Ophthalmology of its 12-month outcomes in the GEMINI study, including results from a Hispanic population subset. The
MENLO PARK, Calif., May 10, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today reported financial results for the quarter ended March 31, 2022. Recent Business Highlights Generated first quarter 2022 total revenue of $14.9 million, an increase
Sight Sciences Reports First Quarter 2022 Financial Results Read More »
Longtime Congresswoman and former President and CEO of the Better Medicare Alliance, Allyson Schwartz, also joins Podimetrics’ Advisory Board SOMERVILLE, Mass., May 12, 2022 — Podimetrics, creator of the FDA-cleared SmartMat™ and integrated clinical care services that can help save the limbs and lives of complex patients with diabetes, today announced four new leadership hires
Podimetrics announces new strategic growth hires Read More »
MENLO PARK, Calif., April 29, 2022 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT) an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced plans to participate in the upcoming Bank of America Healthcare Conference. Sight Sciences’ management is scheduled to present Thursday, May 12, 2022,
Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference Read More »
Pilot designed to use clinical utility and patient outcomes to validate cost savings and address wasted spend and net savings from “trial and error” medicine SAN DIEGO, CA – May 3, 2022 – Mindera Health™, the developer of the groundbreaking Dermal Intelligence™ platform – the first realization of precision medicine in psoriasis, has initiated